Karl Götte

Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.

Frank Riedel, I Zaiss, Denise Herzog et al. · PubMed · 2005 · 163 citations

Immunology, Pathology, Tumor Biology +19

Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.

Vera Balz, Kathrin Scheckenbach, Karl Götte et al. · PubMed · 2003 · 153 citations

Medicine, P53 Inactivation Frequency, Pathology +15

Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.

Frank Riedel, Karl Götte, Joachim Schwalb et al. · International Journal of Oncology · 2000 · 85 citations

Immunology, Pathology, Cancer Biology +21

Treatment of recurrent respiratory papillomatosis with argon plasma coagulation

W. Bergler, M. Hönig, Karl Götte et al. · The Journal of Laryngology & Otology · 1997 · 74 citations

Abstract Extension, Tracheobronchitis, Interventional Pulmonology +12

Topical Estrogens Combined with Argon Plasma Coagulation in the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia

W. Bergler, Haneen Sadick, Frank Riedel et al. · Annals of Otology Rhinology & Laryngology · 2002 · 69 citations

Thrombosis, Hereditary Hemorrhagic Telangiectasia, Topical Estrogens +15